Hae
Aineistot 1-1 / 1
Ex vivo assessment of efficacy of targeted therapies for treatment of HER2-positive parotid gland cancer
(2019-04-09)
HER2 (human epidermal growth factor receptor 2) positive salivary gland carcinomas are extremely rare with incidence lower than 1 % of all cancers worldwide. Unlike other salivary gland neoplasms, HER2+ salivary gland ...